Literature DB >> 9184620

Novel alternatives and supplements to lithium and anticonvulsants for bipolar affective disorder.

S L Dubovsky1, R D Buzan.   

Abstract

BACKGROUND: Most clinicians are familiar with the traditional anticonvulsants as alternatives to lithium in the treatment of bipolar mood disorders.
METHOD: This review of the English, French, German, and Italian language literature on novel treatments, including electroconvulsive therapy, calcium channel blocking agents, antipsychotic drugs, benzodiazepines, thyroid hormone, psychosurgery, and two new antiepileptic drugs, that have not been studied as extensively as lithium, carbamazepine, and valproate but that may have promise as alternatives or supplements to traditional thymoleptics when the standard treatments are not effective or are poorly tolerated. We searched MEDLINE and PSYCHINFO data bases using the keywords bipolar, mood, and/or treatment. We then searched bibliographies of articles retrieved by the first strategy.
RESULTS: The theoretical rationale for each treatment is discussed, followed by a critical discussion of the evidence supporting its efficacy.
CONCLUSION: The potential risks and benefits of each treatment in actual clinical practice are placed in perspective.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184620     DOI: 10.4088/jcp.v58n0509

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  Adjunctive topiramate treatment in refractory obese bipolar patients: a descriptive open label study.

Authors:  A Gabriel
Journal:  Eat Weight Disord       Date:  2007-03       Impact factor: 4.652

2.  Review of the use of Topiramate for treatment of psychiatric disorders.

Authors:  Danilo Arnone
Journal:  Ann Gen Psychiatry       Date:  2005-02-16       Impact factor: 3.455

3.  Psychopharmacology of topiramate: from epilepsy to bipolar disorder.

Authors:  Marco Mula; Andrea E Cavanna; Francesco Monaco
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.